Device
Ended Awarded
- Contract number
- 36C24825N0321
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,583
Award facts
- Contract value 100% obligated
- $16,582.91 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Worth, TX 76109, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is a delivery order issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $16,582.91 firm fixed-price award is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services.
The award was made under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022 and runs through October 2027. This multiple-award FSS contract provides a streamlined procurement vehicle for the VA to efficiently obtain Novocure's innovative cancer treatment technologies for distribution to VA medical centers nationwide. The contract does not utilize any set-aside designations, likely due to the specialized nature of Novocure's medical device offerings. Novocure acts as the prime contractor, delivering its proprietary TTFields therapy products and services directly to VA facilities without the use of subcontractors. This award supports the VA's mission of expanding veterans' access to cutting-edge cancer therapies by enabling VA facilities to offer Novocure's non-invasive treatment option to veteran patients diagnosed with glioblastoma, mesothelioma, and other forms of solid tumor cancers.
Quick answers
Who was awarded contract 36C24825N0321?
36C24825N0321 was awarded to Novocure Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on January 7, 2025.
How much is contract 36C24825N0321 worth?
The government has obligated $16,583 on 36C24825N0321.
Is contract 36C24825N0321 an order under another contract?
Yes. 36C24825N0321 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C24825N0321 competed?
The extent of competition for 36C24825N0321 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award